SCHEMBL967938

SCHEMBL967938

COc1ccc2[nH]c3c(c2c1)CCN(CC(=O)N1CCN(C2CCC2)CC1)C3

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
KDR P35968 3/20 0.51
ALDH1A1 P00352 3/20 0.50
BAZ2B Q9UIF8 1/20 0.50
PARP1 P09874 1/20 0.50
ACHE P22303 1/20 0.46
TSHR P16473 1/20 0.46
KMT2A Q03164 1/20 0.46
CFTR P13569 2/20 0.45
HTR7 P34969 1/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
MAPKAPK2 P49137 2/20 0.44
NPC1 O15118 1/20 0.44
USP2 O75604 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12947884 0.94 BAZ2B (0.56) HDAC1HDAC6KDRALDH1A1BAZ2B
SCHEMBL967791 0.88 NPC1 (0.58) ALDH1A1BAZ2BPARP1ACHEKMT2A
SCHEMBL967925 0.86 ALDH1A1 (0.53) KDRALDH1A1BAZ2BPARP1ACHE
SCHEMBL970353 0.86 PARP1 (0.52) HDAC1HDAC6ALDH1A1BAZ2BPARP1
SCHEMBL13985808 0.86 PARP1 (0.52) ALDH1A1BAZ2BPARP1KMT2AKDM4E
SCHEMBL967959 0.86 USP2 (0.54) ALDH1A1BAZ2BPARP1TSHRKMT2A
SCHEMBL967354 0.84 PARP1 (0.47) HDAC1HDAC6ALDH1A1PARP1ACHE
SCHEMBL968877 0.84 PARP1 (0.47) HDAC1HDAC6ALDH1A1PARP1TSHR
SCHEMBL970324 0.84 ALDH1A1 (0.64) HDAC1HDAC6ALDH1A1PARP1KMT2A
SCHEMBL968649 0.84 PARP1 (0.50) ALDH1A1PARP1KMT2ACFTRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US claimed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 HDAC1 272/4885HDAC6 1016/4885KDR 1143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.